Discovery of 4-amino-2-(thio)phenol derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: Synthesis and biological evaluation. Part II

被引:12
|
作者
Xu, Fuming [1 ]
Zhang, Lei [1 ]
Jia, Yuping [2 ]
Wang, Xuejian [1 ]
Li, Xiaoguang [1 ]
Wen, Qingli [3 ]
Zhang, Yingjie [1 ]
Xu, Wenfang [1 ]
机构
[1] Shandong Univ, Sch Pharm, Dept Med Chem, Jinan 250012, Shandong, Peoples R China
[2] Shandong Inst Pharmaceut Ind, Jinan 250101, Shandong, Peoples R China
[3] Weifang Med Univ, Affiliated Hosp, Weifang 261031, Shandong, Peoples R China
关键词
AKT; ABL; Protein kinase; HUVECs; Rat thoracic aorta rings; TUMOR-GROWTH; IN-VITRO; SULFONAMIDE; ANALOGS; DESIGN; AGENTS;
D O I
10.1016/j.ejmech.2013.07.056
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel series of 4-amino-2-(thio)phenol derivatives were well synthesized. The preliminary biological test revealed that several compounds displayed high specific protein kinase and angiogenesis inhibitory activities compared with previous work mainly because of the substitution of sulfonamide structure for amide fragment. Among which, compound 5i was identified to inhibit protein kinase B/AKT (IC50 = 1.26 mu M) and ABL tyrosine kinase (IC50 = 1.50 mu M) effectively. Meanwhile, compound 5i demonstrated competitive in vitro antiangiogenic activities to Pazopanib in both human umbilical vein endothelial cell (HUVEC) tube formation assay and the rat thoracic aorta rings test. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:191 / 200
页数:10
相关论文
共 50 条
  • [31] Discovery of 6-Arylurea-2-arylbenzoxazole and 6-Arylurea-2-arylbenzimidazole Derivatives as Angiogenesis Inhibitors: Design, Synthesis and in vitro Biological Evaluation
    Zi, Mengli
    Liu, Feifei
    Wu, Di
    Li, Ke
    Zhang, Da
    Zhu, Changcheng
    Zhang, Zhiyun
    Li, Linghua
    Zhang, Conghai
    Xie, Mingjin
    Lin, Jun
    Zhang, Jihong
    Jin, Yi
    CHEMMEDCHEM, 2019, 14 (13) : 1291 - 1302
  • [32] Synthesis and evaluation of aroylthiourea derivatives of 4-β-amino-4′-O-demethyl-4-desoxypodophyllotoxin as novel topoisomerase II inhibitors
    Zhao, Yu
    Ge, Cun Wang
    Wu, Zhong Hua
    Wang, Cheng Niu
    Fang, Jing Huai
    Zhu, Li
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (03) : 901 - 906
  • [33] Synthesis and biological evaluation of novel 4β-(1,3,4-oxadiazole-2-amino)-podophyllotoxin derivatives
    Ren, Jie
    Wu, Lin
    Xin, Wen Qun
    Chen, Xin
    Hu, Kun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4778 - 4782
  • [34] Synthesis, Molecular Modeling and Biological Evaluation of 4-Alkoxyquinazoline Derivatives as Novel Inhibitors of VEGFR2
    Lu, Liang
    Zhao, Ting-Ting
    Liu, Tian-Bao
    Sun, Wen-Xue
    Xu, Chen
    Li, Dong-Dong
    Zhu, Hai-Liang
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2016, 64 (11) : 1570 - 1575
  • [35] Synthesis and biological evaluation of 2-phenol-4-chlorophenyl-6-aryl pyridines as topoisomerase II inhibitors and cytotoxic agents
    Thapa, Pritam
    Kadayat, Tara Man
    Park, Seojeong
    Shin, Somin
    Magar, Til Bahadur Thapa
    Bist, Ganesh
    Shrestha, Aarajana
    Na, Younghwa
    Kwon, Youngjoo
    Lee, Eung-Seok
    BIOORGANIC CHEMISTRY, 2016, 66 : 145 - 159
  • [36] Synthesis and biological evaluation of thio-benzodiazepines as novel small molecule inhibitors of the p53-MDM2 protein-protein interaction
    Zhuang, Chunlin
    Miao, Zhenyuan
    Zhu, Lingjian
    Zhang, Yongqiang
    Guo, Zizhao
    Yao, Jianzhong
    Dong, Guoqiang
    Wang, Shengzheng
    Liu, Yang
    Chen, Hai
    Sheng, Chunquan
    Zhang, Wannian
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (11) : 5654 - 5661
  • [37] Design, Synthesis and Biological Evaluation of a Novel Series of Indole-3-Carboxamide Derivatives for Cancer Treatment as EGFR Inhibitors
    Zhang, Lan
    Deng, Xin-Shan
    Meng, Guang-Peng
    Zhang, Chao
    Liu, Cong-Chong
    Chen, Gu-Zhou
    Jiang, Xu-Liang
    Zhao, Qing-Chun
    Hu, Chun
    LETTERS IN DRUG DESIGN & DISCOVERY, 2018, 15 (01) : 70 - 83
  • [38] Design, synthesis and biological evaluation of pyrrolopyrimidine urea derivatives as novel KRASG12C inhibitors for the treatment of cancer
    Shang, Yanguo
    Pang, Miaomiao
    Fu, Shengnan
    Fei, Wenjuan
    Chen, Boxuan
    Zhang, Yaoyao
    Wang, Jinxin
    Shen, Tao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 289
  • [39] Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110α inhibitors
    Hayakawa, Masahiko
    Kaizawa, Hiroyuki
    Moritomo, Hiroyuki
    Koizumi, Tomonobu
    Ohishi, Takahide
    Okada, Minoru
    Ohta, Mitsuaki
    Tsukamoto, Shin-ichi
    Parker, Peter
    Workman, Paul
    Waterfield, Mike
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (20) : 6847 - 6858
  • [40] Synthesis and biological evaluation of novel 2,4-dianilinopyrimidine derivatives as potent dual janus kinase 2 and histone deacetylases inhibitors
    Zhou, Haiping
    Jiang, Junhao
    Lu, Jinyu
    Ran, Dongzhi
    Gan, Zongjie
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1253